Alejandra Goldman
B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
The Immune-Stimulating Particle Adjuvant (ISPA) as a Versatile Adjuvant Platform for Recombinant Vaccines Against Chronic Toxoplasma gondii Infection.
Journal: Acta tropica
Published: February 09, 2026
The immune-stimulating particle adjuvant (ISPA) as a versatile adjuvant platform for recombinant vaccines against chronic Toxoplasma gondii infection.
Journal: Acta tropica
Published: February 09, 2026
Modulating dendritic cell function in allergic asthma with Toxoplasma gondii serine protease inhibitor 1.
Journal: International immunology
Published: October 28, 2024
Preclinical evaluation of N-acetyl-cysteine in association with liposomes of lung surfactant's lipids for the treatment of pulmonary fibrosis and asthma.
Journal: Toxicology and applied pharmacology
Published: May 27, 2024
Maternal stress increases risk of allergic lung inflammation in adult mice.
Journal: Immunobiology
Published: February 12, 2023
Contribution of Kazal-Like Domains of the Serine Protease Inhibitor-1 from Toxoplasma gondii in Asthma Therapeutic Vaccination Effectiveness.
Journal: International archives of allergy and immunology
Published: April 26, 2021
Azelastine potentiates antiasthmatic dexamethasone effect on a murine asthma model.
Journal: Pharmacology research & perspectives
Published: July 19, 2019
Chronic infection with the protozoan Toxoplasma gondii prevents the development of experimental atopic dermatitis in mice.
Journal: Journal of dermatological science
Published: June 14, 2019
Genotyping of Toxoplasma gondii: The advantages of variable number tandem repeats within coding regions.
Journal: Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
Published: October 21, 2017
Last Updated: 09/26/2026